Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Telix Pharmaceuticals has raised $600.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in April 2026.
Telix Pharmaceuticals's investors include Australian Government.
Telix Pharmaceuticals is headquartered in Melbourne, Australia.
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Telix Pharmaceuticals is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Telix Pharmaceuticals — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/telix-pharmaceuticals. Accessed August 13, 2026.
VCBacked. (2026). Telix Pharmaceuticals — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/telix-pharmaceuticals
{{cite web |title=Telix Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/telix-pharmaceuticals |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated